Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
Quality improvement effort to decrease unnecessary aspirin use tied to decrease in major bleeding without increase in thrombotic events
Thromboembolism
Updated CHEST Guidelines on Antithrombotic Therapy in Venous Thromboembolism
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
Update on Expanded Indications for NOACs Beyond Stroke Prevention
Experts review the current indications for NOACs as well as research on use as venous thromboembolism (VTE) prophylaxis in patients with cancer, who are critically ill, and with peripheral artery disease
New DOAC Users Had Lower Risks for Ischemic Stroke, Major Bleeding vs New Warfarin Users
Study authors assessed the effectiveness and safety of DOACs compared with warfarin in patients with valvular atrial fibrillation.
Venous Thromboembolism Management in Patients With COVID-19
A 61-year-old woman presents to a rural emergency department with complaints of progressively worsening dyspnea for 24 hours and pleuritic chest pain.
ASH 2020 Guidelines on Venous Thromboembolism Management
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Understanding the Association Between COVID-19, Thromboembolism, and Therapeutic Anticoagulation
In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.
COVID-19 May Increase VTE Risk in Pregnant Women, Individuals Taking Estrogen Therapy
Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Risk Factors for Recurrent Venous Thromboembolism in Patients With Sickle Cell Disease
Patients with severe sickle cell disease were more than twice as likely to experience recurrent thromboembolism compared with patients with less severe disease.
- Loading...
Loading...
Next post in Hematology Information Center
Loading... 
Loading...